Background A candidate tetravalent dengue vaccine is being assessed in three clinical
trials involving more than 35,000 children between the ages of 2 and 16 years in Asian–Pacific …

Background Indonesia reports the second highest dengue disease burden in the world; these
data are from passive surveillance reports and are likely to be significant underestimates. …

Background Increases in human population size, dengue vector-density and human mobility
cause rapid spread of dengue virus in Indonesia. We investigated the changes in dengue …

… Tedjo Sasmono, Ari Prayitno and Sri Rezeki Hadinegoro have been investigators for
clinical or epidemiological studies sponsored by Sanofi Pasteur, and have been remunerated …

In Indonesia, pneumococcal disease represents a considerable public health concern;
however, published data on the epidemiology, nasopharyngeal carriage, serotype prevalence, …

Background In 2017, a diphtheria outbreak occurred in several provinces in Indonesia. The
aim of this study was to identify predictors of mortality outcome of pediatric patients with …

Background Common causes of acute febrile illness in tropical countries have similar symptoms,
which often mimic those of dengue. Accurate clinical diagnosis can be difficult without …

Background Dengue is associated with significant economic expenditure and it is estimated
that the Asia Pacific region accounts for >50% of the global cost. Indonesia has one of the …

Colonization with Streptococcus pneumoniae is mostly symptomless, but can progress to
respiratory or even systemic disease. We investigated nasopharyngeal carriage of …

Dengue incidence has increased globally, but empirical burden estimates are scarce.
Prospective methods are best-able to capture all severities of disease. CYD14 was an observer-…